Functional properties of the HIV-1 subtype C envelope glycoprotein associated with mother-to-child transmission

scientific article

Functional properties of the HIV-1 subtype C envelope glycoprotein associated with mother-to-child transmission is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VIROL.2009.12.019
P932PMC publication ID2844456
P698PubMed publication ID20096914
P5875ResearchGate publication ID41122304

P50authorDamien C TullyQ60590429
Piotr KubisQ61117235
Chipepo KankasaQ81697874
P2093author name stringCharles Wood
Jun He
Hong Zhang
John T West
Marzena Rola
P2860cites workNeutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infectionQ24538985
A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individualsQ24560010
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodiesQ24561905
Evolution of subtype C HIV-1 Env in a slowly progressing Zambian infantQ24815687
Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype BQ28469023
Antibody neutralization and escape by HIV-1Q29547345
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibodyQ29618366
Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1Q33402461
Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, KenyaQ33648259
Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B.Q33780595
Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levelsQ33780649
Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartumQ33850575
Construction and analysis of an infectious human Immunodeficiency virus type 1 subtype C molecular cloneQ33851598
Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infantQ34301874
Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South AfricaQ34332009
Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporationQ34333514
Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C.Q34465489
Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1Q34545760
Pediatric HIV-1 infection: advances and remaining challengesQ34630043
Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variantsQ34717113
The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.Q34781878
Characterization of HIV-1 subtype C envelope glycoproteins from perinatally infected children with different courses of diseaseQ35127401
Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern AfricaQ35140032
Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmissionQ35832182
Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporationQ35844026
Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1.Q35857683
Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothersQ36126775
Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.Q36623941
The human immunodeficiency virus type 1 envelope confers higher rates of replicative fitness to perinatally transmitted viruses than to nontransmitted virusesQ36974671
Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from IndiaQ37179996
CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemicQ37191866
Viral characteristics of transmitted HIV.Q37447478
Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation.Q39594428
Phylogenetic and phenotypic analysis of HIV type 1 env gp120 in cases of subtype C mother-to-child transmissionQ39625776
Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patientsQ40953782
Features of HIV-1 that could influence maternal-child transmissionQ41449046
Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolatesQ44219287
Selective transmission of human immunodeficiency virus type-1 variants from mothers to infantsQ45867857
Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmissionQ47878972
HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDSQ56935659
Cloning and characterization of functional subtype A HIV-1 envelope variants transmitted through breastfeedingQ79901994
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectHIV transmissionQ49029021
P304page(s)164-174
P577publication date2010-01-25
P1433published inVirologyQ7934867
P1476titleFunctional properties of the HIV-1 subtype C envelope glycoprotein associated with mother-to-child transmission
P478volume400

Reverse relations

cites work (P2860)
Q36276543A combination of broadly neutralizing HIV-1 monoclonal antibodies targeting distinct epitopes effectively neutralizes variants found in early infection
Q36079874Antibodies elicited by yeast glycoproteins recognize HIV-1 virions and potently neutralize virions with high mannose N-glycans
Q36208081Breast Milk of HIV-Positive Mothers Has Potent and Species-Specific In Vivo HIV-Inhibitory Activity
Q37607872Breast milk and in utero transmission of HIV-1 select for envelope variants with unique molecular signatures
Q33879282Comparative analysis of the fusion efficiency elicited by the envelope glycoprotein V1-V5 regions derived from human immunodeficiency virus type 1 transmitted perinatally.
Q44106801Comparisons of the genetic and neutralization properties of HIV-1 subtype C and CRF07/08_BC env molecular clones isolated from infections in China
Q42207794Determinants in V2C2 region of HIV-1 clade C primary envelopes conferred altered neutralization susceptibilities to IgG1b12 and PG9 monoclonal antibodies in a context-dependent manner
Q39400706Envelope glycoproteins of human immunodeficiency virus type 1 variants issued from mother-infant pairs display a wide spectrum of biological properties
Q34853667HIV-1 autologous antibody neutralization associates with mother to child transmission
Q33842522HIV-1 maternal and infant variants show similar sensitivity to broadly neutralizing antibodies, but sensitivity varies by subtype
Q21131399HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads
Q21131400Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized mice
Q34593647Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies
Q34885869Isolate-specific differences in the conformational dynamics and antigenicity of HIV-1 gp120.
Q36548276Maternal Neutralization-Resistant Virus Variants Do Not Predict Infant HIV Infection Risk
Q39625737Molecular determinants of HIV-1 subtype C coreceptor transition from R5 to R5X4
Q27008774Mother-infant HIV transmission: do maternal HIV-specific antibodies protect the infant?
Q52660832Neutralization Sensitivity of a Novel HIV-1 CRF01_AE Panel of Infectious Molecular Clones.
Q36246315Neutralizing antibody escape during HIV-1 mother-to-child transmission involves conformational masking of distal epitopes in envelope
Q34336058Phenotypic properties of transmitted founder HIV-1
Q36588632Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants
Q34117097Protection in macaques immunized with HIV-1 candidate vaccines can be predicted using the kinetics of their neutralizing antibodies
Q37032195Purification of recombinant vaccinia virus-expressed monomeric HIV-1 gp120 to apparent homogeneity
Q30235024Recent Insights into the HIV/AIDS Pandemic
Q33533351Restricted genetic diversity of HIV-1 subtype C envelope glycoprotein from perinatally infected Zambian infants
Q36634965Short communication: HIV type 1 subtype C variants transmitted through the bottleneck of breastfeeding are sensitive to new generation broadly neutralizing antibodies directed against quaternary and CD4-binding site epitopes
Q27000889The Antibody Response against HIV-1
Q34982698The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with the risk of infant infection
Q36276632The breadth and titer of maternal HIV-1-specific heterologous neutralizing antibodies are not associated with a lower rate of mother-to-child transmission of HIV-1
Q35140408The genetic bottleneck in vertical transmission of subtype C HIV-1 is not driven by selection of especially neutralization-resistant virus from the maternal viral population
Q37365618The role of neutralizing antibodies in prevention of HIV-1 infection: what can we learn from the mother-to-child transmission context?
Q37233074Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs
Q53705746Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses.
Q34806205Variations in the Biological Functions of HIV-1 Clade C Envelope in a SHIV-Infected Rhesus Macaque during Disease Progression

Search more.